Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist - 2Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 3At least 490 protesters killed in Iran, activists say
- 4'Backward and upward and tilted': Spaceflight causes astronauts' brains to shift inside their skulls
- 5The 10 Most Progressive Logical Disclosures
- Holiday destinations for Creature Sweethearts
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Minneapolis ICE shooting live updates: Protests continue over agent's killing of Renee Nicole Good; Walz puts National Guard on standby
- One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- Interpreter Starts Sobbing as 11-Year-Old Testifies About Last Time He Saw His Mom Before She Was Killed in Missile Strike
- How to get rid of your Christmas tree — and the 1 thing to never, ever do with it
- This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
- Manual for Instructive Application for Youngsters
- How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
